Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOV1101 (Cyclosporine + Prednisolone) in Allergic Conjunctivitis
NCT01120132Phase 2Completed
- Sponsor
- Fovea Pharmaceuticals
- Start
- May 2010
- Primary completion
- Aug 2010
- Modality
- Peptides, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of cyclosporine, prednisolone in allergic conjunctivitis (AC), sponsored by Fovea Pharmaceuticals. Started May 2010; status: completed.
02
Drugs
cyclosporineprednisolone
03
Conditions
allergic conjunctivitis (AC)
Beyond the preview
Go deeper on NCT01120132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01120132.